Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 5049
1. Li X, Zhang L, Ahammed GJ, Li ZX, Wei JP, Shen C, Yan P, Zhang LP, Han WY: Stimulation in primary and secondary metabolism by elevated carbon dioxide alters green tea quality in Camellia sinensis L. Sci Rep; 2017 Aug 11;7(1):7937

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stimulation in primary and secondary metabolism by elevated carbon dioxide alters green tea quality in Camellia sinensis L.
  • Nevertheless, the effects of elevated CO<sub>2</sub> on primary and secondary metabolism in tea plants (Camellia sinensis L.) still remain largely unknown.
  • Here we showed that exposure of tea plants to elevated CO<sub>2</sub> (800 µmol mol<sup>-1</sup> for 24 d) remarkably improved both photosynthesis and respiration in tea leaves.
  • Furthermore, elevated CO<sub>2</sub> increased the concentrations of soluble sugar, starch and total carbon, but decreased the total nitrogen concentration, resulting in an increased carbon to nitrogen ratio in tea leaves.
  • Among the tea quality parameters, tea polyphenol, free amino acid and theanine concentrations increased, while the caffeine concentration decreased after CO<sub>2</sub> enrichment.
  • Real-time qPCR analysis revealed that the expression levels of catechins and theanine biosynthetic genes were up-regulated, while that of caffeine synthetic genes were down-regulated in tea leaves when grown under elevated CO<sub>2</sub> condition.
  • These results unveiled profound effects of CO<sub>2</sub> enrichment on photosynthesis and respiration in tea plants, which eventually modulated the biosynthesis of key secondary metabolites towards production of a quality green tea.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plant Physiol Biochem. 2013 Oct;71:132-43 [23911731.001]
  • [Cites] Science. 2015 May 29;348(6238):953-4 [26023112.001]
  • [Cites] Plant Cell Environ. 2006 Jan;29(1):126-37 [17086759.001]
  • [Cites] Phytochemistry. 2008 Feb;69(4):841-56 [18068204.001]
  • [Cites] Plant Physiol Biochem. 2012 Jul;56:35-40 [22579942.001]
  • [Cites] Nutrition. 2010 Oct;26(10):932-8 [20888549.001]
  • [Cites] Planta. 1985 Aug;165(3):397-406 [24241146.001]
  • [Cites] Planta. 1981 Dec;153(4):376-87 [24276943.001]
  • [Cites] Gene. 2012 Mar 10;495(2):205-10 [22226811.001]
  • [Cites] Methods. 2001 Dec;25(4):402-8 [11846609.001]
  • [Cites] Molecules. 2011 May 04;16(5):3761-77 [21544039.001]
  • [Cites] Plant Physiol Biochem. 2016 Sep;106:327-35 [27380366.001]
  • [Cites] J Nutr Biochem. 2002 Feb;13(2):103-111 [11834226.001]
  • [Cites] Plant Cell Environ. 2008 Nov;31(11):1673-87 [18721265.001]
  • [Cites] J Exp Bot. 2015 Apr;66(7):1951-63 [25657213.001]
  • [Cites] J Agric Food Chem. 2006 Apr 5;54(7):2688-94 [16569062.001]
  • [Cites] J Exp Bot. 2002 May;53(371):1081-8 [11971919.001]
  • [Cites] Plant Physiol Biochem. 2014 May;78:49-52 [24632491.001]
  • [Cites] Sci Rep. 2013 Dec 05;3:3433 [24305603.001]
  • [Cites] Phytopathology. 2016 Nov;106(11):1270-1277 [27392179.001]
  • [Cites] Plant Cell Environ. 2010 May;33(5):729-39 [20519018.001]
  • [Cites] Plant Biol (Stuttg). 2015 Jan;17(1):81-9 [24985337.001]
  • [Cites] Biotechnol Adv. 2015 May-Aug;33(3-4):335-42 [25871834.001]
  • [Cites] Int J Mol Sci. 2011 Feb 10;12(2):1101-14 [21541046.001]
  • [Cites] Plant Physiol Biochem. 2015 Dec;97:350-60 [26520678.001]
  • (PMID = 28801632.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T: Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison. Oncotarget; 2017 May 30;8(22):36674-36684

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Direct meta-analysis were performed to summarize the efficacy of candidate chemopreventative agents Dutasteride, Flutamide, Toremifene, Selenium, Green tea components, Lycopene and natural food products combination.
  • Subgroup analysis showed that green tea catechins significantly decreased prostate cancer in HGPIN patients (7.60% vs 23.1%, RR = 0.39, 95% CI: 0.16-10.97, P P = 0.044), with moderate heterogeneity (I2 = 47.9%, 𝟀2 = 1.92, P = 0.166).
  • The adjusted indirect meta-analysis favored green tea catechins over other chemoprevention agents, and significantly when compared to natural food products combination (RR = 0.355, 95% CI: 0.134-0.934).
  • But Green tea catechins showed the superiority to decrease prostate cancer in HGPIN patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Epidemiol. 2017 Jan;27(1):2-7 [28135193.001]
  • [Cites] Cancer Control. 2016 Oct;23 (4):415-423 [27842331.001]
  • [Cites] Eur J Cancer. 2005 Sep;41(13):1889-910 [16005206.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):1234-40 [16424063.001]
  • [Cites] Cancer Causes Control. 2015 Nov;26(11):1521-50 [26354897.001]
  • [Cites] Cancer Prev Res (Phila). 2009 Apr;2(4):377-84 [19336728.001]
  • [Cites] Nutr Cancer. 2015;67(7):1104-12 [26422197.001]
  • [Cites] N Engl J Med. 2010 Apr 1;362(13):1192-202 [20357281.001]
  • [Cites] Prostate. 2015 Aug 1;75(11):1177-86 [25893930.001]
  • [Cites] J Urol. 2008 Dec;180(6):2314-21; discussion 2721-2 [18930254.001]
  • [Cites] Am J Epidemiol. 2008 Jan 1;167(1):71-7 [17906295.001]
  • [Cites] Cancer Cell. 2011 Oct 18;20(4):457-71 [22014572.001]
  • [Cites] Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008007 [22071840.001]
  • [Cites] Urology. 2004 Jun;63(6):1105-10 [15183961.001]
  • [Cites] Endocr Rev. 2004 Apr;25(2):276-308 [15082523.001]
  • [Cites] Cancer Prev Res (Phila). 2015 Oct;8(10 ):879-87 [25873370.001]
  • [Cites] Biochem Pharmacol. 2013 Mar 1;85(5):667-72 [23041649.001]
  • [Cites] World J Surg Oncol. 2014 Feb 14;12:38 [24528523.001]
  • [Cites] Cancer Metastasis Rev. 2010 Sep;29(3):553-68 [20803054.001]
  • [Cites] Am J Ther. 2006 Jul-Aug;13(4):291-7 [16858161.001]
  • [Cites] J Urol. 2006 Sep;176(3):965-70; discussion 970-1 [16890670.001]
  • [Cites] J Clin Pathol. 2007 Apr;60(4):443-6 [16822873.001]
  • [Cites] J Clin Oncol. 2011 Jun 10;29(17):2386-90 [21537051.001]
  • [Cites] Lancet Oncol. 2009 Oct;10(10):981-91 [19796750.001]
  • [Cites] Cancer Prev Res (Phila). 2016 Aug;9(8):648-56 [26813971.001]
  • [Cites] J Urol. 2007 Jul;178(1):107-9; discussion 110 [17499284.001]
  • [Cites] Front Oncol. 2014 Sep 16;4:247 [25279351.001]
  • [Cites] CA Cancer J Clin. 2015 Mar;65(2):87-108 [25651787.001]
  • [Cites] World J Urol. 2017 May;35(5):721-728 [27644229.001]
  • [Cites] Cancer Prev Res (Phila). 2011 Nov;4(11):1761-9 [21896650.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2164-71 [20699373.001]
  • [Cites] J Clin Epidemiol. 1997 Jun;50(6):683-91 [9250266.001]
  • [Cites] Int J Mol Sci. 2016 Aug 31;17 (9): [27589731.001]
  • [Cites] N Engl J Med. 2003 Jul 17;349(3):215-24 [12824459.001]
  • [Cites] Urol Oncol. 2005 Nov-Dec;23(6):383-5 [16301113.001]
  • [Cites] JAMA. 1996 Dec 25;276(24):1957-63 [8971064.001]
  • [Cites] J Clin Oncol. 2013 Feb 10;31(5):523-9 [23295793.001]
  • [Cites] Prostate. 1996 Jan;28(1):17-23 [8545277.001]
  • [Cites] Int J Cancer. 2004 Jan 1;108(1):130-5 [14618627.001]
  • [Cites] Eur J Cancer Prev. 2000 Apr;9(2):125-30 [10830580.001]
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1079-85 [11474294.001]
  • [Cites] Semin Oncol Nurs. 2012 Feb;28(1):29-44 [22281308.001]
  • [Cites] BMJ. 2011 Oct 18;343:d5928 [22008217.001]
  • [Cites] Int J Clin Exp Pathol. 2009;2(4):327-38 [19158990.001]
  • [Cites] JAMA. 2009 Jan 7;301(1):39-51 [19066370.001]
  • [Cites] EPMA J. 2016 Apr 02;7:5 [27042242.001]
  • [Cites] Cancer Res. 2002 Sep 15;62(18):5119-25 [12234971.001]
  • [Cites] Br J Cancer. 2006 Aug 7;95(3):371-3 [16804523.001]
  • (PMID = 28415774.001).
  • [ISSN] 1949-2553
  • [Journal-full-title] Oncotarget
  • [ISO-abbreviation] Oncotarget
  • [Language] eng
  • [Publication-type] Meta-Analysis
  • [Publication-country] United States
  • [Keywords] NOTNLM ; HGPIN / adjusted indirect meta-analysis / chemoprevention / green tea catechins / prostate cancer
  •  go-up   go-down


3. Singhal K, Raj N, Gupta K, Singh S: Probable benefits of green tea with genetic implications. J Oral Maxillofac Pathol; 2017 Jan-Apr;21(1):107-114

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Probable benefits of green tea with genetic implications.
  • Tea is produced from the <i>Camellia sinensis</i> plant and can generally be divided into categories based on how they are processed.
  • In general, green tea that is unfermented <i>C. sinensis</i> has been considered superior to black tea in health benefits.
  • Oral cavity oxidative stress and inflammation, consequent cigarettes due to nicotine and acrolein, may be reduced in the presence of green tea polyphenols.
  • In addition, green tea polyphenols can close down halitosis through modification of odorant sulfur components.
  • Usually, green tea defends healthy cells from malignant transformation and locally has the ability to induce apoptosis in oral cancer cells.
  • In unison, there is an increasing implication in the health benefits of green tea in the field of oral health.
  • This review will cover recent findings on the therapeutic properties and anticancer health benefits of green tea.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Nutr. 2006 Apr;25(2):79-99 [16582024.001]
  • [Cites] Eur J Oral Sci. 2010 Apr;118(2):145-50 [20487003.001]
  • [Cites] Food Chem Toxicol. 1997 Aug;35(8):827-33 [9350228.001]
  • [Cites] J Periodontol. 2009 Mar;80(3):372-7 [19254120.001]
  • [Cites] Br J Nutr. 2009 Dec;102(12):1790-802 [19751534.001]
  • [Cites] Molecules. 2007 May 03;12(5):946-57 [17873830.001]
  • [Cites] J Altern Complement Med. 2005 Jun;11(3):521-8 [15992239.001]
  • [Cites] Eur J Clin Nutr. 1996 Jan;50(1):28-32 [8617188.001]
  • [Cites] Nutrition. 2002 May;18(5):443-4 [11985958.001]
  • [Cites] Caries Res. 1999 Nov-Dec;33(6):441-5 [10529529.001]
  • [Cites] Arch Oral Biol. 2012 May;57(5):429-35 [22226360.001]
  • [Cites] J Periodontal Res. 2002 Dec;37(6):433-8 [12472837.001]
  • [Cites] Anticancer Agents Med Chem. 2006 Sep;6(5):389-406 [17017850.001]
  • [Cites] J Periodontal Res. 2004 Oct;39(5):300-7 [15324350.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4524-9 [10200295.001]
  • [Cites] Biol Psychiatry. 2007 Dec 15;62(12):1353-62 [17624318.001]
  • [Cites] J Periodontol. 1993 Jul;64(7):630-6 [8396176.001]
  • [Cites] Am J Clin Nutr. 2007 Oct;86(4):1243-7 [17921409.001]
  • [Cites] BMC Complement Altern Med. 2014 Aug 30;14:322 [25175005.001]
  • [Cites] Arch Intern Med. 2003 Jun 23;163(12):1448-53 [12824094.001]
  • [Cites] Antiviral Res. 2003 Apr;58(2):167-73 [12742577.001]
  • [Cites] J Indian Soc Periodontol. 2012 Apr;16(2):161-7 [23055579.001]
  • [Cites] J Cell Biochem. 2001;82(3):387-98 [11500915.001]
  • [Cites] Cancer Lett. 1998 Jul 17;129(2):173-9 [9719459.001]
  • [Cites] Arch Biochem Biophys. 2000 Apr 15;376(2):338-46 [10775421.001]
  • [Cites] Int J Cardiol. 2006 Apr 14;108(3):301-8 [15978686.001]
  • [Cites] J Periodontal Res. 2010 Feb;45(1):23-30 [19602116.001]
  • [Cites] Explore (NY). 2006 Nov-Dec;2(6):531-9 [17113495.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):6009-14 [12719524.001]
  • [Cites] J Expo Sci Environ Epidemiol. 2008 Mar;18(2):158-66 [17410113.001]
  • [Cites] Oral Microbiol Immunol. 2004 Apr;19(2):118-20 [14871352.001]
  • [Cites] Biochem Pharmacol. 1999 Sep 15;58(6):911-5 [10509743.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Mar 22;292(1):94-101 [11890677.001]
  • [Cites] Biosci Biotechnol Biochem. 1996 May;60(5):745-9 [8704303.001]
  • [Cites] J Med Chem. 2007 Jan 25;50(2):264-71 [17228868.001]
  • [Cites] Rev Saude Publica. 2004 Feb;38(1):100-5 [14963548.001]
  • [Cites] Antimicrob Agents Chemother. 2004 Jun;48(6):1968-73 [15155186.001]
  • [Cites] Antiviral Res. 1993 Aug;21(4):289-99 [8215301.001]
  • [Cites] Ann N Y Acad Sci. 2001 Apr;928:274-80 [11795518.001]
  • [Cites] J Oral Pathol Med. 2007 Nov;36(10):588-93 [17944751.001]
  • [Cites] Ann Nutr Metab. 2004;48(2):95-102 [14988639.001]
  • [Cites] Clin Nutr. 2006 Oct;25(5):790-6 [16698148.001]
  • [Cites] Proc Soc Exp Biol Med. 1999 Apr;220(4):218-24 [10202392.001]
  • [Cites] J Clin Aesthet Dermatol. 2012 Feb;5(2):34-41 [22468171.001]
  • [Cites] Arch Pharm Res. 1998 Jun;21(3):348-52 [9875456.001]
  • [Cites] Eur J Pharmacol. 2004 Oct 1;500(1-3):177-85 [15464031.001]
  • [Cites] Tob Induc Dis. 2003 Sep 15;1(3):219-26 [19570263.001]
  • [Cites] Comp Biochem Physiol C Toxicol Pharmacol. 2001 Feb;128(2):153-64 [11239828.001]
  • [Cites] Heart. 2004 Dec;90(12):1485-6 [15547040.001]
  • [Cites] J Endod. 2010 Jan;36(1):83-6 [20003940.001]
  • [Cites] Drug Metabol Drug Interact. 2004;20(1-2):43-56 [15283302.001]
  • [Cites] J Am Coll Nutr. 2002 Feb;21(1):1-13 [11838881.001]
  • [Cites] Pharmacol Res. 2011 Aug;64(2):105-12 [21624470.001]
  • [Cites] Exp Toxicol Pathol. 2005 Jul;57 Suppl 1:43-73 [16092717.001]
  • [Cites] Iran J Basic Med Sci. 2012 May;15(3):880-4 [23493325.001]
  • [Cites] J Indian Soc Periodontol. 2011 Jan;15(1):18-22 [21772716.001]
  • [Cites] J Nutr Biochem. 2004 Sep;15(9):506-16 [15350981.001]
  • [Cites] J Immunol. 2003 Apr 15;170(8):4335-41 [12682270.001]
  • [Cites] Phytother Res. 2004 Aug;18(8):624-7 [15476306.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):132-7 [14744744.001]
  • [Cites] J Agric Food Chem. 2004 Mar 24;52(6):1688-92 [15030231.001]
  • [Cites] Toxicol Sci. 2006 Feb;89(2):547-53 [16280382.001]
  • (PMID = 28479696.001).
  • [ISSN] 0973-029X
  • [Journal-full-title] Journal of oral and maxillofacial pathology : JOMFP
  • [ISO-abbreviation] J Oral Maxillofac Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Keywords] NOTNLM ; Antioxidants / Camellia sinensis / cancer / tea
  •  go-up   go-down


Advertisement
4. Teng YS, Wu D: Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG). Pharmacogn Mag; 2017 Apr-Jun;13(50):326-331
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG).
  • BACKGROUND: (-)-Epigallocatechin-3-gallate (EGCG) is the most abundant of the green tea polyphenols that exhibit a variety of bioactivities.
  • <b>Abbreviations used:</b> EGCG: (-)-Epigallocatechin-3-gallate, ROS: reactive oxygen species, BLA: blood lactic acid, SUN: serum urea nitrogen, SOD: superoxide dismutase, GPx: glutathione peroxidase, CAT: catalase, SCK: serum creatine kinase, MDA: malondialdehyde, C: control, LET: Low-dose EGCG-treated, MET: Middle-dose EGCG-treated, HET: High-dose EGCG-treated, GTE: green tea extract.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oxid Med Cell Longev. 2016;2016:3517824 [26904162.001]
  • [Cites] J Nutr Sci Vitaminol (Tokyo). 2006 Aug;52(4):287-92 [17087056.001]
  • [Cites] Life Sci. 2006 Mar 27;78(18):2073-80 [16445946.001]
  • [Cites] Evid Based Complement Alternat Med. 2012;2012:932165 [21941591.001]
  • [Cites] J Int Soc Sports Nutr. 2012 May 18;9(1):23 [22607394.001]
  • [Cites] Am J Phys Med Rehabil. 2007 Jan;86(1 Suppl):S29-46 [17370370.001]
  • [Cites] Basic Clin Pharmacol Toxicol. 2010 Jun;106(6):490-6 [20088847.001]
  • [Cites] Molecules. 2012 Oct 09;17(10):11864-76 [23047485.001]
  • [Cites] Molecules. 2010 Dec 24;16(1):28-37 [21187815.001]
  • [Cites] Am J Chin Med. 2012;40(1):111-20 [22298452.001]
  • [Cites] Nutrition. 2008 Jun;24(6):599-603 [18455659.001]
  • [Cites] Food Chem. 2015 Jan 1;166:287-91 [25053058.001]
  • [Cites] Pharmacogn Mag. 2014 Oct;10(40):458-63 [25422546.001]
  • [Cites] J Ethnopharmacol. 2010 Jul 20;130(2):421-3 [20580802.001]
  • [Cites] Food Funct. 2014 Sep;5(9):2113-9 [25002163.001]
  • [Cites] Evid Based Complement Alternat Med. 2012;2012:364741 [22829854.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2006 Jun;290(6):R1550-6 [16410398.001]
  • [Cites] J Ethnopharmacol. 2013 Nov 25;150(2):529-35 [24036063.001]
  • [Cites] Biofactors. 2014 Nov-Dec;40(6):586-95 [25352148.001]
  • [Cites] Eur J Appl Physiol. 2005 Dec;95(5-6):543-9 [16132121.001]
  • [Cites] Indian J Biochem Biophys. 2014 Aug;51(4):321-5 [25296504.001]
  • [Cites] Int J Med Sci. 2014 Mar 29;11(5):528-37 [24693223.001]
  • [Cites] Nutrition. 2007 May;23(5):419-23 [17483009.001]
  • [Cites] Appl Microbiol Biotechnol. 2006 Mar;70(2):247-53 [15983804.001]
  • [Cites] Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2015 Jan;31(1):85-8 [26016249.001]
  • [Cites] Eur J Appl Physiol. 2006 Sep;98(2):220-6 [16944194.001]
  • [Cites] J Ethnopharmacol. 2004 Jul;93(1):75-81 [15182908.001]
  • [Cites] Tumour Biol. 2014 Aug;35(8):8065-75 [24839007.001]
  • [Cites] Physiol Behav. 2005 Jan 31;84(1):1-7 [15642600.001]
  • (PMID = 28539729.001).
  • [ISSN] 0973-1296
  • [Journal-full-title] Pharmacognosy magazine
  • [ISO-abbreviation] Pharmacogn Mag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; (-)-Epigallocatechin-3-gallate / anti-fatigue / biochemical parameters / forced swimming exercise / mice
  •  go-up   go-down


5. Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ: Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. World J Gastroenterol; 2017 Jun 07;23(21):3805-3814
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
  • AIM: To investigate protective effects and molecular mechanisms of green tea polyphenols (GTP) on non-alcoholic fatty liver disease (NAFLD) in Zucker fatty (ZF) rats.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ Open Gastroenterol. 2016 Nov 9;3(1):e000114 [27933201.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Jan 1;391(1):187-92 [19900410.001]
  • [Cites] Eur J Nutr. 2014 Feb;53(1):187-99 [23515587.001]
  • [Cites] J Ethnopharmacol. 2002 Nov;83(1-2):109-16 [12413715.001]
  • [Cites] Diabetologia. 2016 Jun;59(6):1098-103 [27048250.001]
  • [Cites] J Hepatol. 2013 Sep;59(3):550-6 [23665288.001]
  • [Cites] J Biol Chem. 1978 Nov 25;253(22):8294-300 [711753.001]
  • [Cites] Physiol Rev. 2007 Apr;87(2):507-20 [17429039.001]
  • [Cites] Gut. 2012 Mar;61(3):409-15 [21846782.001]
  • [Cites] Physiol Rev. 2009 Jul;89(3):1025-78 [19584320.001]
  • [Cites] J Biol Chem. 2004 Jul 30;279(31):32345-53 [15166226.001]
  • [Cites] Gastroenterology. 2014 Mar;146(3):726-35 [24316260.001]
  • [Cites] Exp Anim. 2008 Jul;57(4):335-45 [18633156.001]
  • [Cites] Am J Clin Nutr. 2014 Apr;99(4):804-12 [24522441.001]
  • [Cites] Free Radic Biol Med. 2015 Dec;89:679-89 [26456051.001]
  • [Cites] J Dig Dis. 2009 Aug;10(3):201-6 [19659788.001]
  • [Cites] Biomed Res Int. 2013;2013:920128 [24066304.001]
  • [Cites] Int J Hepatol. 2012;2012:212865 [22792473.001]
  • [Cites] Inflammopharmacology. 2016 Oct;24(5):207-219 [27506528.001]
  • [Cites] Int Immunol. 2010 May;22(5):347-52 [20410258.001]
  • [Cites] Food Chem. 2013 Dec 15;141(4):3627-35 [23993530.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E730-E740 [27577854.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39 [26670487.001]
  • [Cites] J Agric Food Chem. 2012 Jul 25;60(29):7152-7 [22730927.001]
  • [Cites] J Clin Exp Hepatol. 2012 Jun;2(2):145-55 [25755423.001]
  • [Cites] Gut. 2017 Jan;66(1):180-190 [27646933.001]
  • [Cites] Gastroenterology. 2011 Jan;140(1):124-31 [20858492.001]
  • [Cites] Diabetes Obes Metab. 2010 Oct;12 Suppl 2:83-92 [21029304.001]
  • [Cites] J Agric Food Chem. 2006 Mar 8;54(5):1906-13 [16506852.001]
  • [Cites] J Nutr Biochem. 2003 Jun;14(6):326-32 [12873714.001]
  • [Cites] J Lipid Res. 2012 Apr;53(4):792-801 [22323564.001]
  • [Cites] J Agric Food Chem. 2015 Mar 25;63(11):2979-88 [25756465.001]
  • (PMID = 28638220.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; AMP-activated protein kinase / Green tea polyphenols / Hepatic lipogenesis / Inflammatory cytokines / Non-alcoholic fatty liver disease
  •  go-up   go-down


6. Lassed S, Deus CM, Djebbari R, Zama D, Oliveira PJ, Rizvanov AA, Dahdouh A, Benayache F, Benayache S: Protective Effect of Green Tea (&lt;i&gt;Camellia sinensis&lt;/i&gt; (L.) Kuntze) against Prostate Cancer: From In Vitro Data to Algerian Patients. Evid Based Complement Alternat Med; 2017;2017:1691568
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Protective Effect of Green Tea (<i>Camellia sinensis</i> (L.) Kuntze) against Prostate Cancer: From In Vitro Data to Algerian Patients.
  • Green tea (GT) has been studied for its effects as antioxidant and cancer-preventive agent.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 2015 Mar 1;136(5):E359-86 [25220842.001]
  • [Cites] Oncogene. 2003 Jul 31;22(31):4851-9 [12894226.001]
  • [Cites] J Agric Food Chem. 2001 Nov;49(11):5340-7 [11714326.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):598-605 [17372258.001]
  • [Cites] J Lab Clin Med. 1963 May;61:882-8 [13967893.001]
  • [Cites] Free Radic Res. 2010 May;44(5):479-96 [20370557.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):1234-40 [16424063.001]
  • [Cites] Cancer. 2003 Mar 15;97(6):1442-6 [12627508.001]
  • [Cites] Clin Cancer Res. 2007 Jul 1;13(13):3796-802 [17606710.001]
  • [Cites] Chem Res Toxicol. 2000 Sep;13(9):801-10 [10995252.001]
  • [Cites] Indian J Clin Biochem. 2005 Jul;20(2):162-5 [23105552.001]
  • [Cites] FASEB J. 2011 Apr;25(4):1198-207 [21177307.001]
  • [Cites] Oxid Med Cell Longev. 2012;2012:789870 [23365695.001]
  • [Cites] Nutr Cancer. 2013;65(6):793-801 [23909722.001]
  • [Cites] Clin Biochem. 2009 Aug;42(12):1228-35 [19465015.001]
  • [Cites] Am J Epidemiol. 2008 Jan 1;167(1):71-7 [17906295.001]
  • [Cites] Nutr Cancer. 2015;67(5):796-803 [25996655.001]
  • [Cites] Biomed Pharmacother. 2011 Oct;65(7):516-24 [21993000.001]
  • [Cites] Mar Drugs. 2012 May;10(5):1126-37 [22822361.001]
  • [Cites] Cancer Prev Res (Phila). 2009 Jul;2(7):673-82 [19542190.001]
  • [Cites] Curr Drug Targets. 2012 Dec;13(14):1738-49 [23140285.001]
  • [Cites] Biochim Biophys Acta. 2009 Apr;1795(2):83-91 [19121370.001]
  • [Cites] Free Radic Biol Med. 2001 Sep 15;31(6):824-31 [11557321.001]
  • [Cites] Carcinogenesis. 2004 Jun;25(6):1011-4 [14764460.001]
  • [Cites] J Ethnopharmacol. 1999 Aug;66(2):141-50 [10433470.001]
  • [Cites] Prostate Int. 2016 Sep;4(3):71-87 [27689064.001]
  • [Cites] Hum Pathol. 2002 Mar;33(3):299-306 [11979370.001]
  • [Cites] Iran J Basic Med Sci. 2014 Oct;17(10):740-6 [25729541.001]
  • [Cites] Hum Pathol. 1992 Mar;23 (3):211-22 [1372877.001]
  • [Cites] Cancer Res. 2008 Mar 15;68(6):1777-85 [18339858.001]
  • [Cites] Exp Oncol. 2008 Sep;30(3):244-7 [18806750.001]
  • [Cites] Invest Urol. 1979 Jul;17(1):16-23 [447482.001]
  • [Cites] Oncol Rep. 2011 Jul;26(1):177-84 [21503582.001]
  • [Cites] Methods Enzymol. 1990;186:421-31 [2233309.001]
  • [Cites] Cancer Lett. 2009 Sep 18;282(2):125-36 [19185987.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10350-5 [11504910.001]
  • [Cites] J Nat Prod. 2001 Jul;64(7):892-5 [11473417.001]
  • [Cites] Chem Biol Interact. 2008 Jan 10;171(1):89-95 [17931610.001]
  • [Cites] Toxicol Appl Pharmacol. 2000 Apr 1;164(1):82-90 [10739747.001]
  • [Cites] Int J Cancer. 2004 Jan 1;108(1):130-5 [14618627.001]
  • [Cites] Urology. 1993 Oct;42(4):365-74 [7692657.001]
  • [Cites] Prostate. 2007 Oct 1;67(14):1576-89 [17705241.001]
  • [Cites] Life Sci. 1998;63(16):1397-403 [9952285.001]
  • [Cites] BJU Int. 2008 Aug;102(3):371-82 [18476967.001]
  • [Cites] Br J Cancer. 2006 Aug 7;95(3):371-3 [16804523.001]
  • [Cites] Cancer Metastasis Rev. 2002;21(1):3-16 [12400993.001]
  • [Cites] Int J Biol Macromol. 2009 Oct 1;45(3):231-5 [19481106.001]
  • [Cites] Invest New Drugs. 2015 Feb;33(1):64-74 [25404486.001]
  • (PMID = 28133488.001).
  • [ISSN] 1741-427X
  • [Journal-full-title] Evidence-based complementary and alternative medicine : eCAM
  • [ISO-abbreviation] Evid Based Complement Alternat Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Naponelli V, Ramazzina I, Lenzi C, Bettuzzi S, Rizzi F: Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges. Antioxidants (Basel); 2017 Apr 05;6(2)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.
  • Green tea catechins (GTCs) are a family of chemically related compounds usually classified as antioxidant molecules.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Epidemiol. 2017 Jan;27(1):2-7 [28135193.001]
  • [Cites] Eur J Cancer Prev. 2008 Nov;17 (6):489-501 [18941371.001]
  • [Cites] Oncogene. 2003 Jul 31;22(31):4851-9 [12894226.001]
  • [Cites] Int J Hyperthermia. 2010;26(8):737-47 [20858068.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):598-605 [17372258.001]
  • [Cites] Mutat Res. 2005 Dec 11;591(1-2):147-60 [15992833.001]
  • [Cites] Cancer Res. 2002 Dec 15;62(24):7241-6 [12499265.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):1234-40 [16424063.001]
  • [Cites] Pol J Vet Sci. 2007;10(1):57-60 [17388027.001]
  • [Cites] Cancer. 2003 Mar 15;97(6):1442-6 [12627508.001]
  • [Cites] Cancer Res. 2007 Jul 1;67(13):6493-501 [17616711.001]
  • [Cites] J Exp Ther Oncol. 2005;5(1):69-78 [16416603.001]
  • [Cites] Carcinogenesis. 2014 Apr;35(4):828-39 [24343359.001]
  • [Cites] Carcinogenesis. 2004 Nov;25(11):2217-24 [15358631.001]
  • [Cites] FASEB J. 2005 May;19(7):807-9 [15738004.001]
  • [Cites] Clin Cancer Res. 2005 Jun 15;11(12):4627-33 [15958649.001]
  • [Cites] Cancer Causes Control. 2004 Nov;15(9):911-20 [15577293.001]
  • [Cites] Cancer Res. 2009 Mar 1;69(5):1712-6 [19223530.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12426-31 [22802668.001]
  • [Cites] Biochem Pharmacol. 2011 Dec 15;82(12):1807-21 [21827739.001]
  • [Cites] Nanomedicine (Lond). 2011 Jan;6(1):79-87 [21182420.001]
  • [Cites] Mutat Res. 2001 Sep 1;480-481:243-68 [11506818.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7563-70 [14633667.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):53-8 [11205489.001]
  • [Cites] FASEB J. 2011 Apr;25(4):1198-207 [21177307.001]
  • [Cites] Front Biosci (Schol Ed). 2012 Jan 01;4:412-31 [22202068.001]
  • [Cites] Int J Biochem Cell Biol. 2007;39(12):2215-25 [17683969.001]
  • [Cites] Anticancer Res. 2004 Mar-Apr;24(2B):943-54 [15161048.001]
  • [Cites] Epigenomics. 2013 Dec;5(6):729-41 [24283885.001]
  • [Cites] J Natl Cancer Inst. 1997 Dec 17;89(24):1881-6 [9414176.001]
  • [Cites] Nanomedicine (Lond). 2016 Jan;11(1):9-30 [26654241.001]
  • [Cites] Semin Cancer Biol. 2016 Oct;40-41:35-47 [27038646.001]
  • [Cites] J Natl Cancer Inst. 2000 Sep 20;92 (18):1472-89 [10995803.001]
  • [Cites] Arch Toxicol. 2013 Jan;87(1):19-48 [22885793.001]
  • [Cites] Eur Urol. 2016 Nov;70(5):862-874 [27289567.001]
  • [Cites] Biochem Pharmacol. 2010 Oct 15;80(8):1115-24 [20599789.001]
  • [Cites] Eur Urol. 2008 Aug;54(2):472-3 [18406041.001]
  • [Cites] Am J Pathol. 2005 Sep;167(3):761-73 [16127155.001]
  • [Cites] Clin Cancer Res. 2009 Mar 15;15(6):1947-53 [19276266.001]
  • [Cites] Cancer Sci. 2004 Mar;95(3):238-42 [15016323.001]
  • [Cites] Cancer Res. 1989 Apr 1;49(7):1857-60 [2924323.001]
  • [Cites] Biochem J. 2012 Apr 15;443(2):525-34 [22257159.001]
  • [Cites] Am J Epidemiol. 2008 Jan 1;167(1):71-7 [17906295.001]
  • [Cites] Sci Rep. 2017 Feb 01;7:41573 [28145499.001]
  • [Cites] Biochim Biophys Acta. 2008 Apr;1785(2):182-206 [18166162.001]
  • [Cites] J Med Chem. 2009 Nov 12;52(21):6543-5 [19839593.001]
  • [Cites] Asian Pac J Cancer Prev. 2016;17 (4):1649-54 [27221834.001]
  • [Cites] Biochem Pharmacol. 2012 May 15;83(10):1319-30 [22248733.001]
  • [Cites] Nat Rev Drug Discov. 2013 Dec;12(12):931-47 [24287781.001]
  • [Cites] Redox Biol. 2014 Jan 30;2:323-32 [24563850.001]
  • [Cites] J Cell Biochem. 1997 Oct 1;67(1):55-65 [9328839.001]
  • [Cites] Biofactors. 2004;21(1-4):383-5 [15630231.001]
  • [Cites] Oncol Rep. 2015 Apr;33(4):1976-84 [25682960.001]
  • [Cites] Curr Cancer Drug Targets. 2011 Mar;11(3):296-306 [21247384.001]
  • [Cites] PLoS One. 2010 Apr 21;5(4):e10189 [20422004.001]
  • [Cites] Cancer Prev Res (Phila). 2010 Aug;3(8):985-93 [20628004.001]
  • [Cites] Biotechnol J. 2010 Oct;5(10):1050-9 [20931601.001]
  • [Cites] Cancer Prev Res (Phila). 2009 Jul;2(7):673-82 [19542190.001]
  • [Cites] Cancer Lett. 2002 Jun 28;180(2):139-44 [12175544.001]
  • [Cites] Sci Rep. 2015 Oct 16;5:15270 [26471237.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Sep 22;348(2):524-31 [16889749.001]
  • [Cites] Chem Phys Lipids. 2016 Jun;198:51-60 [27234272.001]
  • [Cites] Carcinogenesis. 2008 Oct;29(10):1986-93 [18586691.001]
  • [Cites] J Inherit Metab Dis. 2017 Jul;40(4):471-480 [28229250.001]
  • [Cites] J Agric Food Chem. 2010 Jan 27;58(2):1296-304 [20041649.001]
  • [Cites] Pharmacol Res. 2010 Dec;62(6):457-64 [20691268.001]
  • [Cites] Cancer Control. 2007 Jan;14(1):78-85 [17242674.001]
  • [Cites] Cell. 2011 Mar 4;144(5):646-74 [21376230.001]
  • [Cites] Cancer Res. 2006 Mar 1;66(5):2500-5 [16510563.001]
  • [Cites] Antioxid Redox Signal. 2014 Apr 1;20(10):1599-617 [23581847.001]
  • [Cites] Prostate. 2004 Apr 1;59(1):33-42 [14991864.001]
  • [Cites] Oncotarget. 2016 Oct 25;7(43):70794-70802 [28053292.001]
  • [Cites] FEMS Yeast Res. 2014 Feb;14(1):33-9 [23965186.001]
  • [Cites] Urology. 2000 Apr;55(4):553-9 [10736500.001]
  • [Cites] Clin Cancer Res. 2003 Aug 15;9(9):3312-9 [12960117.001]
  • [Cites] J Biol Chem. 2008 Feb 8;283(6):3050-8 [18079119.001]
  • [Cites] Phytomedicine. 2010 Jan;17(1):3-13 [19959000.001]
  • [Cites] Br J Cancer. 1991 Jun;63(6):963-6 [2069852.001]
  • [Cites] J Nutr Biochem. 2012 Nov;23(11):1537-42 [22405694.001]
  • [Cites] J Nutr. 2006 Jul;136(7):1839-43 [16772446.001]
  • [Cites] Biosci Biotechnol Biochem. 1999 Sep;63(9):1621-3 [10610125.001]
  • [Cites] Nutrients. 2016 May 20;8(5): [27213442.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):351-4 [9568793.001]
  • [Cites] Prostate Int. 2016 Sep;4(3):71-87 [27689064.001]
  • [Cites] Clin Cancer Res. 2003 Aug 15;9(9):3486-91 [12960141.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Nov 20;389(3):527-30 [19744467.001]
  • [Cites] Chem Commun (Camb). 2017 Feb 7;53(12 ):1941-1944 [28079202.001]
  • [Cites] J Toxicol. 2011;2011:467305 [21776260.001]
  • [Cites] Arch Biochem Biophys. 2010 Sep 1;501(1):65-72 [20558130.001]
  • [Cites] Cancer Lett. 2008 Apr 8;262(1):10-8 [18164805.001]
  • [Cites] Redox Biol. 2014 Jan 10;2:187-95 [24494192.001]
  • [Cites] J Biol Chem. 2001 Apr 20;276(16):13322-30 [11278274.001]
  • [Cites] Front Oncol. 2015 Feb 24;5:47 [25759792.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):652-5 [11830514.001]
  • [Cites] Oxid Med Cell Longev. 2012;2012:984219 [22666523.001]
  • [Cites] Int J Oncol. 2012 Jul;41(1):353-61 [22552582.001]
  • [Cites] Pharm Res. 2008 Sep;25(9):2135-42 [18317887.001]
  • [Cites] Mutat Res. 2007 Dec 1;634(1-2):177-83 [17851114.001]
  • [Cites] Int J Pharm. 2017 Feb 25;518(1-2):220-227 [27988378.001]
  • [Cites] Biochem Pharmacol. 2013 Mar 15;85(6):705-17 [23219527.001]
  • [Cites] Cancer Prev Res (Phila). 2012 Feb;5(2):290-8 [22044694.001]
  • [Cites] Am J Clin Nutr. 2013 Dec;98(6 Suppl):1642S-1650S [24172299.001]
  • [Cites] Urology. 2011 Aug;78(2):475.e15-21 [21676444.001]
  • [Cites] Cent European J Urol. 2014;67(2):136-41 [25140226.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Jun 24;273(1):50-3 [10873562.001]
  • [Cites] J Hepatol. 2004 Jan;40(1):52-9 [14672614.001]
  • [Cites] Curr Opin Oncol. 2016 May;28(3):241-7 [26907571.001]
  • [Cites] J Nat Prod. 2014 Feb 28;77(2):250-7 [24456004.001]
  • [Cites] Int J Cancer. 2004 Dec 10;112(5):823-9 [15386368.001]
  • [Cites] Mol Nutr Food Res. 2011 Jun;55(6):844-54 [21538850.001]
  • [Cites] Mol Cell. 2012 Oct 26;48(2):158-67 [23102266.001]
  • [Cites] Mol Carcinog. 2009 Feb;48(2):91-104 [18618599.001]
  • [Cites] Cancer Lett. 2009 Sep 18;282(2):125-36 [19185987.001]
  • [Cites] Biophys Chem. 1997 Apr 22;65(2-3):157-64 [9175270.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10350-5 [11504910.001]
  • [Cites] Prostate. 2013 Mar;73(4):376-81 [22926960.001]
  • [Cites] Mol Nutr Food Res. 2011 Jun;55(6):832-43 [21538846.001]
  • [Cites] Biol Trace Elem Res. 2009 Dec;131(3):298-310 [19326061.001]
  • [Cites] Cancer Res. 2009 Sep 15;69(18):7165-9 [19738047.001]
  • [Cites] Mol Carcinog. 2014 Jan;53(1):8-18 [22833520.001]
  • [Cites] Carcinogenesis. 2014 Feb;35(2):415-23 [24072771.001]
  • [Cites] Life Sci. 2001 Jan 26;68(10):1207-14 [11228105.001]
  • [Cites] Cancer Prev Res (Phila). 2009 Dec;2(12):1065-75 [19934341.001]
  • [Cites] PLoS One. 2012;7(5):e37942 [22666419.001]
  • [Cites] Prostate. 2006 Jan 1;66(1):57-69 [16114064.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Oct 21;336(2):674-81 [16140266.001]
  • [Cites] Chem Biol Interact. 2008 Jan 10;171(1):89-95 [17931610.001]
  • [Cites] Mol Nutr Food Res. 2009 Feb;53(2):171-84 [19101947.001]
  • [Cites] Toxicol Pathol. 2003 Jan-Feb;31(1):39-51 [12597448.001]
  • [Cites] Cancer Res. 2004 Dec 1;64(23):8715-22 [15574782.001]
  • [Cites] Mol Carcinog. 2010 Aug;49(8):739-49 [20623641.001]
  • [Cites] Cancers (Basel). 2015 Sep 03;7(3):1758-84 [26404379.001]
  • [Cites] Biomed Pharmacother. 2016 Dec;84:340-347 [27668533.001]
  • [Cites] J Cancer Prev. 2016 Mar;21(1):1-12 [27051643.001]
  • [Cites] Int J Cancer. 2010 Jun 1;126(11):2520-33 [19856314.001]
  • [Cites] Crit Rev Food Sci Nutr. 2003;43(1):89-143 [12587987.001]
  • [Cites] J Tradit Complement Med. 2013 Jan;3(1):69-79 [24716158.001]
  • [Cites] Mol Pharmacol. 2005 Oct;68(4):1018-30 [16037419.001]
  • [Cites] Nat Struct Mol Biol. 2004 Apr;11(4):380-1 [15024383.001]
  • [Cites] Int J Cancer. 2004 Jan 1;108(1):130-5 [14618627.001]
  • [Cites] J Biol Chem. 2004 May 7;279(19):20096-107 [14985350.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):1047-53 [16314398.001]
  • [Cites] Mol Nutr Food Res. 2011 Jun;55(6):905-20 [21538852.001]
  • [Cites] Mol Cancer Ther. 2005 Oct;4(10 ):1515-20 [16227400.001]
  • [Cites] Am J Pathol. 2010 Dec;177(6):3169-79 [20971741.001]
  • [Cites] Mol Nutr Food Res. 2008 Apr;52(4):465-71 [18324707.001]
  • [Cites] Prostate. 2007 Oct 1;67(14):1576-89 [17705241.001]
  • [Cites] J Med Chem. 2011 Mar 10;54(5):1321-32 [21306166.001]
  • [Cites] Nutr Cancer. 2012;64(1):4-22 [22098273.001]
  • [Cites] Biosci Biotechnol Biochem. 2001 Jan;65(1):126-32 [11272815.001]
  • [Cites] Mol Med. 2002 Jul;8(7):382-92 [12393936.001]
  • [Cites] Br J Cancer. 2006 Aug 7;95(3):371-3 [16804523.001]
  • [Cites] Free Radic Biol Med. 2009 Nov 1;47(9):1304-9 [19666107.001]
  • [Cites] J Biol Chem. 2005 Jul 22;280(29):26796-804 [15917253.001]
  • [Cites] Sci Rep. 2017 Jan 04;7:40003 [28051150.001]
  • [Cites] Hepatol Res. 2016 Jul 26;:null [27457249.001]
  • [Cites] Int J Oncol. 2011 Dec;39(6):1521-7 [21935569.001]
  • [Cites] Cancer Prev Res (Phila). 2015 Mar;8(3):249-57 [25604133.001]
  • [Cites] Clin Cancer Res. 2005 Apr 1;11(7):2735-46 [15814656.001]
  • [Cites] PLoS One. 2015 Aug 28;10(8):e0136530 [26317853.001]
  • [Cites] J Zhejiang Univ Sci B. 2009 Jun;10(6):411-21 [19489106.001]
  • [Cites] Biomed Res Int. 2015;2015:121826 [25821782.001]
  • (PMID = 28379200.001).
  • [ISSN] 2076-3921
  • [Journal-full-title] Antioxidants (Basel, Switzerland)
  • [ISO-abbreviation] Antioxidants (Basel)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; antioxidant / chemoprevention / green tea catechins / mechanism of action / nanochemoprevention / prostate cancer
  •  go-up   go-down


8. Dekant W, Fujii K, Shibata E, Morita O, Shimotoyodome A: Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements. Toxicol Lett; 2017 Aug 05;277:104-108
Hazardous Substances Data Bank. Green tea .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements.
  • The safety of green tea infusions and green tea extract (GTE)-based products is reviewed regarding catechins.
  • Epigallocatechin 3-gallate (EGCG), the major catechin present in green tea, is suspected of being responsible for liver toxicity reported in humans consuming food supplements.
  • Intake of EGCG with green tea infusions and GTE-based beverages is up to about 450mg EGCG/person/day in Europe and higher in Asia.
  • Consumption of green tea is not associated with liver damage in humans, and green tea infusion and GTE-based beverages are considered safe in the range of historical uses.
  • Use of NOAELs from bolus administration to derive a tolerable upper intake level applying the margin of safety concept results in acceptable EGCG-doses lower than those from one cup of green tea.
  • Thus, a tolerable upper intake level of 300mg EGCG/person/day is proposed for food supplements; this gives a twofold safety margin to clinical studies that did not report liver effects and a margin of safety of 100 to the NOAELs in animal studies with dietary administration of green tea catechins.
  • [MeSH-major] Camellia sinensis / chemistry. Catechin / analogs & derivatives. Dietary Supplements. Food Safety. Plant Extracts / analysis. Tea / chemistry. Teas, Herbal / analysis
  • [MeSH-minor] Animals. Consumer Product Safety. Hazard Analysis and Critical Control Points. Humans. No-Observed-Adverse-Effect Level. Recommended Dietary Allowances. Risk Assessment

  • MedlinePlus Health Information. consumer health - Dietary Supplements.
  • MedlinePlus Health Information. consumer health - Food Safety.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28655517.001).
  • [ISSN] 1879-3169
  • [Journal-full-title] Toxicology letters
  • [ISO-abbreviation] Toxicol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Plant Extracts; 0 / Tea; 0 / Teas, Herbal; 8R1V1STN48 / Catechin; BQM438CTEL / epigallocatechin gallate
  • [Keywords] NOTNLM ; Catechins / Food supplements / Green tea / Safety assessment
  •  go-up   go-down


9. Borutinskaitė V, Virkšaitė A, Gudelytė G, Navakauskienė R: Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells. Leuk Lymphoma; 2018 Feb;59(2):469-478
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
  • Green tea (Camellia sinensis) catechin epigallocatechin-3-gallate (EGCG) has been shown to possess diverse anti-cancerous properties.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28641467.001).
  • [ISSN] 1029-2403
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; EGCG / acute promyelocytic leukemia / epigenetics
  •  go-up   go-down


10. Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Macis D, Mora S, Caldarella P, Pagani G, Pruneri G, Riva A, Petrangolini G, Morazzoni P, DeCensi A, Bonanni B: A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer. Cancer Prev Res (Phila); 2017 Jun;10(6):363-370

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.
  • Epidemiologic data support an inverse association between green tea intake and breast cancer risk.
  • Greenselect Phytosome (GSP) is a lecithin formulation of a caffeine-free green tea catechin extract.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2017 American Association for Cancer Research.
  • (PMID = 28400479.001).
  • [ISSN] 1940-6215
  • [Journal-full-title] Cancer prevention research (Philadelphia, Pa.)
  • [ISO-abbreviation] Cancer Prev Res (Phila)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement